Amarin Corp Plc (AMRN)

[ziploc_1]

F....In this stage of Amarin's development, earnings are less important than revenues....Earnings are mainly a function of how much Amarin decides to spend on marketing this year...and, with FDA approval of expanded indications for Vascepa in the wings, Amarin will be spending an increased amount on marketing...especially in Q4 2019, in order to produce an anticipated explosion in revenues.